STOCK TITAN

Tilray to Report Third Quarter 2020 Financial Results on November 9, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

NANAIMO, British Columbia--()--Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the third quarter ended September 30, 2020 on Monday, November 9, 2020 after market close.

The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-407-0792 from the U.S. and 201-689-8263 internationally.

There will also be a simultaneous, live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived after the conference call concludes.

About Tilray®

Tilray (Nasdaq: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents.

Contacts

Media: Tilray Media Team +1-833-206-8161, news@tilray.com
Investors: Raphael Gross, +1-203-682-8253, Raphael.Gross@icrinc.com

Tilray Brands, Inc.

NASDAQ:TLRY

TLRY Rankings

TLRY Latest News

TLRY Stock Data

1.56B
770.48M
1.33%
10.98%
15.42%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
NEW YORK

About TLRY

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.